| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 11, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 55,000 | $0.30 | $16,231.00 | -0.1% | - | - | |
| Oct 7, 2021 | NBIX Neurocrine Biosciences Inc | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 8,000 | $104.81 | $838,510.30 | -4.6% | -19.2% | +5.1% | |
| Oct 7, 2021 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $190.52 | $1,143,144.44 | -5.0% | -1.6% | +5.5% | |
| Oct 7, 2021 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 3,000 | $18.00 | $54,000.00 | -4.5% | -30.5% | -40.4% | |
| Oct 7, 2021 | NBIX Neurocrine Biosciences Inc | Lyons Gary A54 | Director | Sell | 5,000 | $105.06 | $525,293.50 | -2.3% | -19.2% | +5.1% | |
| Oct 4, 2021 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 987 | $101.73 | $100,407.51 | -6.2% | -12.2% | +8.4% | |
| Oct 1, 2021 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 17,000 | $18.23 | $309,843.70 | -20.2% | -15.6% | -38.0% | |
| Oct 1, 2021 | ZTS Zoetis Inc. | Trawicki Roman48 | Executive Vice President | Sell | 4,497 | $194.14 | $873,047.58 | -100% | +25.1% | -23.9% | |
| Oct 1, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 20,000 | $0.30 | $6,000.00 | - | - | - | |
| Sep 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 315 | $2.83 | $891.15 | - | +76.5% | -10.1% | |
| Sep 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 315 | $2.83 | $891.15 | +0.1% | +76.5% | -10.1% | |
| Sep 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 882 | $2.83 | $2,495.22 | +0.3% | +76.5% | -10.1% | |
| Sep 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth55 | Director | Buy | 1,785 | $2.83 | $5,049.85 | - | +76.5% | -10.1% | |
| Sep 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Cearnal Martin E47 | Sr Vp/ Chief Commercial Officer | Buy | 2,205 | $2.83 | $6,238.05 | - | +76.5% | -10.1% | |
| Sep 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 2,982 | $2.83 | $8,436.22 | +0.4% | +76.5% | -10.1% | |
| Sep 29, 2021 | INM Inmed Pharmaceuticals Inc. | Adams Eric A | President &CEO | Buy | 8,800 | $1.73 | $15,224.00 | +32.0% | -25.8% | -87.4% | |
| Sep 28, 2021 | INM Inmed Pharmaceuticals Inc. | Adams Eric A | President &CEO | Buy | 11,400 | $1.75 | $19,984.20 | +70.9% | -22.5% | -87.2% | |
| Sep 28, 2021 | INM Inmed Pharmaceuticals Inc. | Colwill Bruce | CFO | Buy | 5,000 | $1.77 | $8,840.00 | +330.0% | -22.5% | -87.2% | |
| Sep 24, 2021 | HROW Harrow, Inc. | Lindstrom Richard L Md65 | Director | Sell | 3,900 | $10.04 | $39,156.00 | -5.6% | -3.1% | -15.8% | |
| Sep 23, 2021 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 1,315 | $202.17 | $265,853.55 | -5.7% | +18.1% | -26.2% | |
| Sep 23, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 64,000 | $0.29 | $18,457.20 | - | - | - | |
| Sep 20, 2021 | BMY Bristol Myers Squibb Co | Caforio Giovanni59 | Board Chair And CEO | Sell | 25,000 | $60.64 | $1,516,000.00 | -4.9% | +2.8% | +18.9% | |
| Sep 16, 2021 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $204.08 | $1,224,466.95 | -7.2% | -4.6% | +6.3% | |
| Sep 16, 2021 | HROW Harrow, Inc. | Lindstrom Richard L Md65 | Director | Sell | 20,000 | $9.07 | $181,391.20 | -12.1% | -6.9% | -2.2% | |
| Sep 15, 2021 | TKNO Alpha Teknova, Inc. | Davis Ted | Director, 10% Owner | Buy | 1,429 | $27.08 | $38,697.32 | - | -33.3% | -84.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.